Modular architecture allows AP systems to be assembled from independent (but compatible) modules, each performing a specific function, e.g. prevention of hypoglycemia, post-meal insulin corrections, fine tuning of basal rate, or administration of ancillary compounds such as amylin or glucagon (Kovatchev et al. 2009b). The gene discussed is INS; the disease is Hypoglycemia.